Boyd Rachel J, McClymont Sarah A, Barrientos Nelson B, Hook Paul W, Law William D, Rose Rebecca J, Waite Eric L, Avramopoulos Dimitrios, McCallion Andrew S
McKusick-Nathans Department of Genetic Medicine, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.
Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA.
bioRxiv. 2023 Feb 1:2023.01.23.525270. doi: 10.1101/2023.01.23.525270.
To overcome the ethical and technical limitations of human disease models, the broader scientific community frequently employs model organism-derived cell lines to investigate of disease mechanisms, pathways, and therapeutic strategies. Despite the widespread use of certain models, many still lack contemporary genomic analysis supporting their use as a proxy for the affected human cells and tissues. Consequently, it is imperative to determine how accurately and effectively any proposed biological surrogate may reflect the biological processes it is assumed to model. One such cellular surrogate of human disease is the established mouse neural precursor cell line, SN4741, which has been used to elucidate mechanisms of neurotoxicity in Parkinson disease for over 25 years. Here, we are using a combination of classic and contemporary genomic techniques - karyotyping, RT-qPCR, single cell RNA-seq, bulk RNA-seq, and ATAC-seq - to characterize the transcriptional landscape, chromatin landscape, and genomic architecture of this cell line, and evaluate its suitability as a proxy for midbrain dopaminergic neurons in the study of Parkinson disease. We find that SN4741 cells possess an unstable triploidy and consistently exhibits low expression of dopaminergic neuron markers across assays, even when the cell line is shifted to the non-permissive temperature that drives differentiation. The transcriptional signatures of SN4741 cells suggest that they are maintained in an undifferentiated state at the permissive temperature and differentiate into immature neurons at the non-permissive temperature; however, they may not be dopaminergic neuron precursors, as previously suggested. Additionally, the chromatin landscapes of SN4741 cells, in both the differentiated and undifferentiated states, are not concordant with the open chromatin profiles of , mouse E15.5 forebrain- or midbrain-derived dopaminergic neurons. Overall, our data suggest that SN4741 cells may reflect early aspects of neuronal differentiation but are likely not a suitable a proxy for dopaminergic neurons as previously thought. The implications of this study extend broadly, illuminating the need for robust biological and genomic rationale underpinning the use of models of molecular processes.
为克服人类疾病模型在伦理和技术方面的局限性,广大科学界经常使用源自模式生物的细胞系来研究疾病机制、信号通路和治疗策略。尽管某些模型被广泛使用,但许多模型仍缺乏当代基因组分析来支持其作为受影响人类细胞和组织的替代物。因此,必须确定任何提议的生物替代物能多准确有效地反映其假定模拟的生物过程。人类疾病的一种此类细胞替代物是已建立的小鼠神经前体细胞系SN4741,在超过25年的时间里,它一直被用于阐明帕金森病的神经毒性机制。在此,我们使用经典和当代基因组技术的组合——核型分析、逆转录定量聚合酶链反应(RT-qPCR)、单细胞RNA测序、批量RNA测序和转座酶可及染色质测序(ATAC-seq)——来表征该细胞系的转录图谱、染色质图谱和基因组结构,并评估其作为帕金森病研究中中脑多巴胺能神经元替代物的适用性。我们发现SN4741细胞具有不稳定的三倍体,并且在各种检测中始终表现出多巴胺能神经元标志物的低表达,即使该细胞系转移到驱动分化的非允许温度下也是如此。SN4741细胞的转录特征表明,它们在允许温度下维持未分化状态,在非允许温度下分化为未成熟神经元;然而,它们可能不像先前认为的那样是多巴胺能神经元前体。此外,SN4741细胞在分化和未分化状态下的染色质图谱与小鼠E15.5前脑或中脑来源的多巴胺能神经元的开放染色质图谱不一致。总体而言,我们的数据表明SN4741细胞可能反映神经元分化的早期方面,但可能不像先前认为的那样是多巴胺能神经元的合适替代物。这项研究的影响广泛,揭示了在分子过程模型的使用中需要强大生物学和基因组学依据的必要性。